Search Results

Displaying Results 1-5 of 5 "'IOBT'"

Jun 18, 2026, 16:11 ET US C5ISR Funding Reaches $42.7 Billion as AI, Open Architectures, and Next-Generation Technologies Reshape Defense Modernization

next-generation networking capabilities. Frost & Sullivan identifies quantum technologies, edge integration, and the Internet of Battlefield Things (IoBT) as key growth opportunities expected to shape the future of the C5ISR ecosystem."Modern military operations increasingly depend on secure, interoperable,

More news about: Frost & Sullivan


Jun 18, 2026, 16:11 ET US C5ISR Funding Reaches $42.7 Billion as AI, Open Architectures, and Next-Generation Technologies Reshape Defense Modernization

next-generation networking capabilities. Frost & Sullivan identifies quantum technologies, edge integration, and the Internet of Battlefield Things (IoBT) as key growth opportunities expected to shape the future of the C5ISR ecosystem."Modern military operations increasingly depend on secure, interoperable,

More news about: Frost & Sullivan


Oct 27, 2025, 08:30 ET Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

Therapeutics is focused on making its mark in the oncology treatment space, along with other innovative leaders such as IO Biotech Inc. (NASDAQ: IOBT), Novartis AG (NYSE: NVS), Bicara Therapeutics Inc. (NASDAQ: BCAX) and Pfizer Inc. (NYSE: PFE)

More news about: NetworkNewsWire


Oct 07, 2025, 09:00 ET Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

immunotherapy developers including GT Biopharma, Inc. (NASDAQ: GTBP), Leap Therapeutics, Inc. (NASDAQ: LPTX), IO Biotech (NASDAQ: IOBT), Celcuity Inc. (NASDAQ: CELC), and MAIA Biotechnology, Inc. (NYSE-American: MAIA).

More news about: USA News Group


Sep 15, 2025, 08:30 ET Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

other leading innovators in the cancer and rare disease treatment space, including IO Biotech Inc. (NASDAQ: IOBT), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Autolus Therapeutics PLC (NASDAQ:

More news about: NetworkNewsWire


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.